Assessment for Mild Cognitive Impairment Clinical Practice Guidelines (AAN, 2019)

American Academy of Neurology (AAN)

This is a quick summary of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

October 01, 2019

The quality improvement recommendations for assessment for mild cognitive impairment (MCI) were released on September 18, 2019, by the American Academy of Neurology (AAN).[1]

Perform annual cognitive assessment for patients aged 65 years or older. Adults older than 65 years are at high risk for cognitive impairment because of their age, and patients older than 65 years who have neurologic illnesses are at even greater risk.

Perform cognitive and functional assessment for patients with MCI or memory loss. This is essential for distinguishing MCI from insignificant cognitive complaints on one hand and from dementia syndrome on the other.

Disclose the MCI diagnosis to patients and care partners, and provide counseling on treatment options.

Assess and treat factors contributing to MCI (eg, hepatic or renal failure, depression, sleep disturbance, medication side effects, or psychiatric illnesses).

Avoid anticholinergic medications in patients with MCI. Many older adults may have memory problems due solely to these agents.

Educate care partners of patients with MCI. Doing so enhances the autonomy and well-being of both patients and care partners.

For more information, please go to Mild Cognitive Impairment and Screening for Cognitive Impairment.

For more Clinical Practice Guidelines, please go to Guidelines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.